Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$127,561
in 3 filings, $17K under 10b5-1 plans

Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-01 Huizenga Theodore Alan SVP, Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +7,400 7,400
2022-03-01 Huang Dennis Karl See Remarks Sale −3,234 $66.62 $215K 36,914
2022-03-01 Huang Dennis Karl See Remarks Grant or award +14,000 51,040
2022-03-01 Huang Dennis Karl See Remarks Grant or award · Stock Option (Right to Buy) +24,900 24,900
2022-03-01 Parschauer Karah Herdman EVP and Chief Legal Officer Sale −2,886 $66.62 $192K 25,472
2022-03-01 Parschauer Karah Herdman EVP and Chief Legal Officer Grant or award +14,000 39,578
2022-03-01 Parschauer Karah Herdman EVP and Chief Legal Officer Grant or award · Stock Option (Right to Buy) +24,900 24,900
2022-03-01 Kassberg Thomas Richard CBO & EVP Sale −2,374 $66.62 $158K 213,840
2022-03-01 Kassberg Thomas Richard CBO & EVP Grant or award +14,000 227,840
2022-03-01 Kassberg Thomas Richard CBO & EVP Grant or award · Stock Option (Right to Buy) +24,900 24,900
2022-03-01 Bedrosian Camille L EVP and Chief Medical Officer Sale −2,821 $66.62 $188K 33,938
2022-03-01 Bedrosian Camille L EVP and Chief Medical Officer Grant or award +14,000 47,938
2022-03-01 Bedrosian Camille L EVP and Chief Medical Officer Grant or award · Stock Option (Right to Buy) +24,900 24,900
2022-03-01 KAKKIS EMIL D President & CEO Shares withheld for taxes −12,162 $67.37 $819K 582,185
2022-03-01 KAKKIS EMIL D President & CEO Grant or award +52,041 634,226
2022-03-01 KAKKIS EMIL D President & CEO Grant or award · Stock Option (Right to Buy) +92,360 92,360
2022-01-30 Bedrosian Camille L EVP and Chief Medical Officer Sale −1,657 $66.30 $110K 36,759
2021-10-14 Bedrosian Camille L EVP and Chief Medical Officer Sale −359 $81.14 $29K 38,416
2021-10-14 Harris Erik EVP & Chief Commercial Officer Sale −303 $81.14 $25K 25,030
2021-10-14 Huang Dennis Karl EVP & Chief Tech Ops Officer Sale −358 $81.14 $29K 40,148

Page 17 of 21 · 410 trades